Capillary Technologies reports Q2 FY27 profit, changes auditor

Capillary Technologies India Limited reported unaudited financial results for the quarter ended September 30, 2026, including consolidated revenue from operations of ₹2,713.55 million and consolidated profit of ₹219.16 million. The board also appointed Deloitte Touche Tohmatsu India LLP as internal auditor, effective November 2, 2026.

What did Capillary Technologies India Limited report for Q2 FY27?

Capillary Technologies India Limited said its board approved unaudited standalone and consolidated financial results for the quarter and half-year ended September 30, 2026, at its meeting on November 2, 2026. The disclosure covers the second quarter of FY27 and sets out operating revenue, total income, expenses and profit for the reported period.

On a standalone basis, Capillary Technologies reported revenue from operations of ₹842.58 million for the quarter. Total income was ₹881.06 million and total expenses were ₹468.11 million. Standalone profit for the quarter was ₹294.31 million. The company also reported standalone profit of ₹294.31 million for the half-year ended September 30, 2026.

The company said the quarterly standalone profit represented an increase from the prior-year period, though the provided results summary does not state the corresponding prior-year profit figure. The figures were approved as unaudited results, which is the standard format for quarterly reporting before annual audited accounts are completed.

How did Capillary Technologies perform on a consolidated basis?

Capillary Technologies reported consolidated revenue from operations of ₹2,713.55 million for Q2 FY27. Consolidated total income stood at ₹2,774.14 million, while total expenses were ₹2,318.77 million for the quarter ended September 30, 2026.

Consolidated profit for the quarter was ₹219.16 million. The company also disclosed consolidated profit of ₹219.16 million for the half-year ended September 30, 2026. The announcement does not provide comparable year-earlier consolidated figures, margins, earnings per share or segment-wise performance.

The difference between standalone and consolidated disclosures reflects the two reporting scopes used in corporate financial statements. Standalone numbers relate to the company on its own, while consolidated numbers include the financial results of the company together with entities covered under its consolidation framework.

Why did Capillary Technologies change its internal auditor?

Capillary Technologies appointed M/s. Deloitte Touche Tohmatsu India LLP as its internal auditor with effect from November 2, 2026. The board approved the appointment at the same meeting in which it considered the Q2 FY27 financial results.

Deloitte Touche Tohmatsu India LLP replaces M/s. Protiviti India Member Private Limited in the internal audit role. The company’s disclosure identifies the change and its effective date, but does not state a reason for replacing the previous internal auditor or specify the tenure of the new appointment.

An internal auditor assesses internal controls, risk-management processes and operational compliance for management and the board. This role is separate from the statutory auditor’s role in auditing and reporting on a company’s financial statements. The announcement concerns an internal audit appointment and does not indicate a change in statutory auditor.

What events preceded the Q2 FY27 results announcement?

Capillary Technologies had earlier scheduled an earnings conference call for November 2, 2026 at 4:00 PM IST to discuss its Q2 and H1 FY27 financial results with analysts and investors. The call was disclosed through a Regulation 30 announcement dated October 26, 2026.

The company had also reported Q1 FY27 operating revenue of ₹2,566 million, up 43% year-on-year, in its August 2026 investor presentation. That presentation said adjusted EBITDA rose 132% year-on-year to ₹440 million, representing a 17% margin. Those Q1 figures are separate from the Q2 results approved on November 2.

Before the results period, Capillary Technologies scheduled analyst and institutional investor interactions, including an October 1, 2026 meeting. Such engagements provide investors with access to company updates, but the reported Q2 results and auditor appointment are the formal board-approved developments in the latest disclosure.

What do the Q2 FY27 disclosures mean for investors?

Capillary Technologies’ announcement gives investors updated standalone and consolidated profit and revenue figures for the quarter ended September 30, 2026. Consolidated revenue from operations of ₹2,713.55 million is the largest operating figure disclosed in the release, while the ₹219.16 million consolidated profit provides the corresponding reported earnings measure.

The internal auditor change is relevant to governance and oversight because the internal audit function reviews a company’s controls and processes. However, the company did not provide additional details on the transition, its scope or its expected financial effect. Investors therefore have no disclosed basis in this announcement to quantify an impact from the appointment.

The scheduled earnings call is the next identified forum for management to discuss the quarterly and half-year results. Investors may look for any comments that the company makes on financial performance, operating conditions and the auditor transition, while distinguishing management commentary from the board-approved financial disclosures.

Conclusion

Capillary Technologies India Limited closed Q2 FY27 with standalone revenue from operations of ₹842.58 million and consolidated revenue from operations of ₹2,713.55 million. It reported standalone profit of ₹294.31 million and consolidated profit of ₹219.16 million, while also changing its internal auditor from Protiviti India Member Private Limited to Deloitte Touche Tohmatsu India LLP.

The company had scheduled its Q2 and H1 FY27 earnings conference call for November 2, 2026 at 4:00 PM IST. Investors will watch for management’s discussion of the reported results and any further disclosed information on the internal audit transition, since the board announcement does not provide a reason for the change or additional implementation details.